Krystal Biotech, Inc. (KRYS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2016: $15.0K2017: $210.0K2018: $2.23M2019: $6.40M2020: $14.84M2021: $68.34M2022: $52.98M2023: $11.80M2024: $4.24M2025: $11.95M$11.95M
2016Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$11.95M+182.0%
2024$4.24M-64.1%
2023$11.80M-77.7%
2022$52.98M-22.5%
2021$68.34M+360.4%
2020$14.84M+132.0%
2019$6.40M+186.4%
2018$2.23M+963.8%
2017$210.0K+1300.0%
2016$15.0K